Tag: clinical trial safety

Serious vs Non-Serious Adverse Events: When to Report in Clinical Trials

Serious vs Non-Serious Adverse Events: When to Report in Clinical Trials

Learn the critical difference between serious and non-serious adverse events in clinical trials-and when each must be reported. Understand the six FDA criteria, avoid common mistakes, and ensure patient safety without overwhelming the system.

RECENT POSTS

May 16, 2023
The Connection between Atrophic Gastroenteritis and Gastric Cancer

As a blogger, I've come across some interesting information about the connection between atrophic gastritis and gastric cancer. Atrophic gastritis is a chronic inflammation of the stomach lining, which leads to the loss of gastric glandular cells and their eventual replacement by intestinal and fibrous tissues. This condition is considered a significant risk factor for gastric cancer, as it causes a gradual decline in gastric acid production and an increase in the production of gastrin, a hormone that promotes cell growth. With the loss of normal stomach function, the risk of developing gastric cancer significantly increases, especially in cases of autoimmune or H. pylori-induced gastritis. It's crucial to monitor and manage atrophic gastritis symptoms to reduce the risk of gastric cancer and maintain overall digestive health.

November 18, 2025
Albendazole Resistance: Why It Happens and How to Fix It

Albendazole resistance is rising in many parts of the world due to overuse and underdosing. Learn why it happens, how it spreads, and what combinations and practices actually work when the drug fails.

December 11, 2025
Why Patients Skip or Forget Medications: Common Barriers to Adherence

Many patients skip or forget medications due to complex schedules, high costs, poor communication, and forgetfulness-not laziness. Learn the real reasons behind nonadherence and what actually works to fix it.

May 9, 2023
The Role of Atenolol-Chlorthalidone in Managing Heart Failure

As a blogger, I've come across a crucial topic in managing heart failure - the role of Atenolol-Chlorthalidone. This combination of medications is known to effectively treat high blood pressure, which is a significant risk factor for heart failure. Atenolol, a beta-blocker, helps in reducing the heart rate and blood pressure, while Chlorthalidone, a diuretic, aids in eliminating excess fluid from the body. Together, they work to reduce the workload on the heart, ultimately improving its function and decreasing the risk of heart failure. It's essential to consult with your doctor for proper dosage and prescription to ensure the best possible outcome in managing heart failure.

December 30, 2025
Generic Drug Interactions: How Digital Consultation Tools Keep You Safe

Digital tools can help you avoid dangerous interactions between generic drugs, but not all apps are equal. Learn which ones actually work, what they miss, and how to stay safe when buying meds online.